Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,390 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
Kwong WJ, Ozer-Stillman I, Miller JD, Haber NA, Russell MW, Kavanagh S. Kwong WJ, et al. Among authors: miller jd. Clin Ther. 2010 Sep;32(10):1768-81. doi: 10.1016/j.clinthera.2010.09.011. Clin Ther. 2010. PMID: 21194601
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J. Brown JS, et al. Among authors: miller jd. Headache. 2005 Sep;45(8):1012-22. doi: 10.1111/j.1526-4610.2005.05182.x. Headache. 2005. PMID: 16109115
Cost-effectiveness of Telaprevir combination therapy for chronic hepatitis C.
Brogan AJ, Talbird SE, Thompson JR, Miller JD, Rubin J, Deniz B. Brogan AJ, et al. Among authors: miller jd. PLoS One. 2014 Mar 6;9(3):e90295. doi: 10.1371/journal.pone.0090295. eCollection 2014. PLoS One. 2014. PMID: 24603445 Free PMC article.
Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Caloyeras JP, Zhang B, Wang C, Eriksson M, Fredrikson S, Beckmann K, Knappertz V, Pohl C, Hartung HP, Shah D, Miller JD, Sandbrink R, Lanius V, Gondek K, Russell MW. Caloyeras JP, et al. Among authors: miller jd. Clin Ther. 2012 May;34(5):1132-44. doi: 10.1016/j.clinthera.2012.03.004. Epub 2012 Apr 27. Clin Ther. 2012. PMID: 22541587
Cost-effectiveness of statins.
Huse DM, Russell MW, Miller JD, Kraemer DF, D'Agostino RB, Ellison RC, Hartz SC. Huse DM, et al. Among authors: miller jd. Am J Cardiol. 1998 Dec 1;82(11):1357-63. doi: 10.1016/s0002-9149(98)00641-9. Am J Cardiol. 1998. PMID: 9856919
Cost effectiveness of HMG-CoA reductase inhibition in Canada.
Russell MW, Huse DM, Miller JD, Kraemer DF, Hartz SC. Russell MW, et al. Among authors: miller jd. Can J Clin Pharmacol. 2001 Spring;8(1):9-16. Can J Clin Pharmacol. 2001. PMID: 11283756
The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.
Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R, Russell MW. Foster TS, et al. Among authors: miller jd. Cancer Treat Rev. 2011 Oct;37(6):405-15. doi: 10.1016/j.ctrv.2010.12.008. Epub 2011 Apr 8. Cancer Treat Rev. 2011. PMID: 21477928 Review.
Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty: a retrospective analysis.
Krotenberg R, Adler U, Pomeranz B, Miller JD, Russell MW. Krotenberg R, et al. Among authors: miller jd. Am J Phys Med Rehabil. 2001 Dec;80(12):889-95. doi: 10.1097/00002060-200112000-00004. Am J Phys Med Rehabil. 2001. PMID: 11821667
Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.
Zhang B, Donga PZ, Corral M, Sasane M, Miller JD, Pashos CL. Zhang B, et al. Among authors: miller jd. Pharmacoeconomics. 2011 Jun;29(6):461-74. doi: 10.2165/11589250-000000000-00000. Pharmacoeconomics. 2011. PMID: 21452907 Review.
Economic burden of follicular non-Hodgkin's lymphoma.
Foster T, Miller JD, Boye ME, Russell MW. Foster T, et al. Among authors: miller jd. Pharmacoeconomics. 2009;27(8):657-79. doi: 10.2165/11314820-000000000-00000. Pharmacoeconomics. 2009. PMID: 19712009 Review.
1,390 results
Jump to page